Ocular Therapeutix, Inc. (OCUL)
10.64
-0.26
(-2.39%)
USD |
NASDAQ |
Sep 03, 16:00
10.64
0.00 (0.00%)
After-Hours: 20:00
Ocular Therapeutix Net Income (Annual) : -265.94M for Dec. 31, 2025
Net Income (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -265.94M |
| December 31, 2024 | -193.51M |
| December 31, 2023 | -80.74M |
| December 31, 2022 | -71.04M |
| December 31, 2021 | -6.553M |
| December 31, 2020 | -155.64M |
| December 31, 2019 | -86.37M |
| Date | Value |
|---|---|
| December 31, 2018 | -59.98M |
| December 31, 2017 | -63.39M |
| December 31, 2016 | -44.70M |
| December 31, 2015 | -39.75M |
| December 31, 2014 | -28.65M |
| December 31, 2013 | -13.34M |
| December 31, 2012 | -14.13M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| EyePoint, Inc. | -231.96M |
| LENZ Therapeutics, Inc. | -82.13M |
| Merck & Co., Inc. | 18.26B |
| Theravance Biopharma, Inc. | 105.90M |
| ANI Pharmaceuticals, Inc. | 71.37M |